0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Livestock Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Livestock Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Livestock Pharmaceuticals Market: Product (Anti-infectives/ Antibiotics, Parasiticides, Reproduction Management, Vaccines, Others), Animal (Cattle, Sheep, Goats, Swine, Horses, Others), Distribution Channel (Veterinary Hospitals, veterinary Pharmacies, Others), and Geography

 

 

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,
Report

Description

Livestock Pharmaceuticals Market size was valued at USD 18.2 billion in 2021 and is expected to reach a value of USD 30.79 billion by 2028, at a CAGR of 7.8% during the forecast period 2022-28. Livestock pharmaceuticals market is used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed. Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with Sanofi’s Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.

Key Developments:

In July 2017, ECO Animal Health received FDA approval for Aivlosin an antibiotic used in the treatment of major enteric and respiratory diseases in poultry and swine

In March 2017, Merck Animal Health acquired Brazilian company Vallee S.A. for strengthening its livestock pharmaceuticals product portfolio

Livestock Pharmaceuticals Market

MARKET SUMMARY
-
7.8%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.8%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Livestock Pharmaceuticals Market

  • The report on global livestock pharmaceuticals market gives historical, current and future market sizes (US$ Bn) based on by product type, by product type, by end-user and region.
  • livestock pharmaceuticals market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Merck Animal Health
  • Zoetis Inc.
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Bayer Animal Health
  • Virbac Inc.
  • Heska Corporation
Livestock Pharmaceuticals Market

Drivers And Restraints

Increase in the prevalence of various livestock diseases such as bird flu in poultry, rise in animal welfare expenditure, government initiatives for the animal health management, and rise in demand for healthy meat and other livestock products are anticipated to fuel the livestock pharmaceuticals market. Moreover, rise in disposable income, increase in the awareness about livestock diseases and treatment, and rise in R&D activities for the innovation of newer therapeutics and vaccines might bolster the growth of the market. However, stringent regulatory guidelines for veterinary medicine approval, ban of certain antibiotics used in the animal diseases, poor availability of drugs in the underdeveloped regions, and dearth of skilled veterinary professionals are hampering the growth of the market.

North-America got significant share

Livestock Pharmaceuticals Market

Geographically, livestock pharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Increase in the R&D activities for the development of newer drugs by several U.S. pharmaceutical companies, rise in awareness about the veterinary diseases and treatment, increase in the animal welfare expenditure, and rise in product approvals for livestock diseases are anticipated to propel the North America livestock pharmaceuticals market. Europe livestock pharmaceuticals market growth driven by rise in the production of aquatic animals in Norway, Denmark, Ireland, and other European countries, increase in the demand for healthy meat and other livestock products, rise in the disposable income, and increase in the prevalence of zoonotic diseases. However, Asia Pacific livestock pharmaceuticals market growing at significant rate owing to increase in population demanding for quality meat, launching of newer drugs in Asia Pacific region, and industrialization of poultry sector in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Livestock Pharmaceuticals Market Segmentation

segmentation-block-image

Drug Class

segmentation-block-image

Disease Type

    • Neurological disorders
    • Infectious diseases
    • Viral diseases
    • Bacterial diseases
    • Fungal diseases
    • Others
segmentation-block-image

Route Administration

    • Oral
    • Parenteral
    • Topical
    • Others
segmentation-block-image

Distribution Channel

    • Veterinary hospitals
    • Veterinary pharmacies
    • Online pharmacies
Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

1. Executive Summary
2. Global Livestock Pharmaceuticals Market Introduction
2.1. Global Livestock Pharmaceuticals Market – Taxonomy
2.2. Global Livestock Pharmaceuticals Market –Definitions
2.2.1. Product
2.2.2. Animal
2.2.3. Distribution Channel
3. Global Livestock Pharmaceuticals Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Livestock Pharmaceuticals Market Dynamic Factors – Impact Analysis
3.6. Global Livestock Pharmaceuticals Market – Competition Landscape
4. Global Livestock Pharmaceuticals Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Livestock Pharmaceuticals Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
5.1. Anti-infectives/ Antibiotics
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Parasiticides
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Reproduction Management
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Vaccines
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. High-density Polyethylene (HDPE)
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Livestock Pharmaceuticals Market Forecast, By Animal, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Cattle
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Sheep
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Goats
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Swine
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Horses
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Livestock Pharmaceuticals Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Region, 2022 – 2028
8. North America Livestock Pharmaceuticals Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
8.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Anti-infectives/ Antibiotics
8.1.2. Parasiticides
8.1.3. Reproduction Management
8.1.4. Vaccines
8.1.5. Others
8.2. Animal Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Cattle
8.2.2. Sheep
8.2.3. Goats
8.2.4. Swine
8.2.5. Horses
8.2.6. Others
8.3. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.3.1. Veterinary Hospitals
8.3.2. veterinary Pharmacies
8.3.3. Others
8.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.4.1. USA
8.4.2. Canada
8.5. North America Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2022 – 2028
8.6. North America Livestock Pharmaceuticals Market Dynamics – Trends
9. Europe Livestock Pharmaceuticals Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
9.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Anti-infectives/ Antibiotics
9.1.2. Parasiticides
9.1.3. Reproduction Management
9.1.4. Vaccines
9.1.5. Others
9.2. Animal Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Cattle
9.2.2. Sheep
9.2.3. Goats
9.2.4. Swine
9.2.5. Horses
9.2.6. Others
9.3. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Veterinary Hospitals
9.3.2. veterinary Pharmacies
9.3.3. Others
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. Germany
9.4.2. UK
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Poland
9.4.8. Rest of Europe
9.5. Europe Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Raw Material Type, End -Use and Country, 2022 – 2028
9.6. Europe Livestock Pharmaceuticals Market Dynamics – Trends
10. Asia-Pacific Livestock Pharmaceuticals Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
10.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Anti-infectives/ Antibiotics
10.1.2. Parasiticides
10.1.3. Reproduction Management
10.1.4. Vaccines
10.1.5. Others
10.2. Animal Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Cattle
10.2.2. Sheep
10.2.3. Goats
10.2.4. Swine
10.2.5. Horses
10.2.6. Others
10.3. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Veterinary Hospitals
10.3.2. veterinary Pharmacies
10.3.3. Others
10.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. ASEAN
10.4.5. Australia & New Zealand
10.4.6. Rest of Asia-Pacific
10.5. Asia-Pacific Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2022 – 2028
10.6. Asia-Pacific Livestock Pharmaceuticals Market Dynamics – Trends
11. Latin America Livestock Pharmaceuticals Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
11.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Anti-infectives/ Antibiotics
11.1.2. Parasiticides
11.1.3. Reproduction Management
11.1.4. Vaccines
11.1.5. Others
11.2. Animal Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Cattle
11.2.2. Sheep
11.2.3. Goats
11.2.4. Swine
11.2.5. Horses
11.2.6. Others
11.3. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Veterinary Hospitals
11.3.2. veterinary Pharmacies
11.3.3. Others
11.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
11.5. Latin America Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2022 – 2028
11.6. Latin America Livestock Pharmaceuticals Market Dynamics – Trends
12. Middle East and Africa Livestock Pharmaceuticals Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
12.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Anti-infectives/ Antibiotics
12.1.2. Parasiticides
12.1.3. Reproduction Management
12.1.4. Vaccines
12.1.5. Others
12.2. Animal Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Cattle
12.2.2. Sheep
12.2.3. Goats
12.2.4. Swine
12.2.5. Horses
12.2.6. Others
12.3. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Veterinary Hospitals
12.3.2. veterinary Pharmacies
12.3.3. Others
12.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Gulf Cooperation Council (GCC) Countries
12.4.2. Israel
12.4.3. South Africa
12.4.4. Rest of MEA
12.5. MEA Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2022 – 2028
12.6. MEA Livestock Pharmaceuticals Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Feedstock Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Zoetis Inc. (U.S)
13.2.2. Virbac S.A. (France)
13.2.3. Vétoquinol S.A. (France)
13.2.4. Merck & Co., Inc. (U.S)
13.2.5. Bayer AG (Germnay)
13.2.6. Boehringer Ingelheim GmbH (Germany)
13.2.7. Ceva Santé Animale (France)
13.2.8. Eli Lilly and Company (U.S)
13.2.9. Hester biosciences (India)
14. Research Methodology
15. Key Assumptions and Acronyms
Report

Company Profile

  • Zoetis Inc. (U.S)
  • Virbac S.A. (France)
  • Vétoquinol S.A. (France)
  • Merck & Co., Inc. (U.S)
  • Bayer AG (Germnay)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Hester biosciences (India)

Description

Livestock Pharmaceuticals Market size was valued at USD 18.2 billion in 2021 and is expected to reach a value of USD 30.79 billion by 2028, at a CAGR of 7.8% during the forecast period 2022-28. Livestock pharmaceuticals market is used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed. Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with Sanofi’s Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.

Key Developments:

In July 2017, ECO Animal Health received FDA approval for Aivlosin an antibiotic used in the treatment of major enteric and respiratory diseases in poultry and swine

In March 2017, Merck Animal Health acquired Brazilian company Vallee S.A. for strengthening its livestock pharmaceuticals product portfolio

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+